PET/CT vs CT for initial lung cancer staging
Part of Cancer, Lungs & breathing clinical trials.
This study compares two types of scans (a special PET/CT called F-18 FDG and regular CT) to see how well they show the extent of non-small cell lung cancer before any treatment starts. It may help doctors choose the right approach for your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with non-small cell lung cancer (a common type of lung cancer).
- You must be at least 18 years old.
- You must not have started any treatment for this lung cancer yet.
- Your blood sugar level must be less than 200 mg/dL (which usually means diabetes needs to be well controlled).
- You must not have any other active cancer besides this lung cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a two-step nuclear imaging scan (SPECT/CT) versus a PET/CT scan to see which works better for lung cancer. It may help guide doctors on the most useful imaging approach before you start lung-cancer treatment.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This trial uses a special type of PET/CT scan (called FDG PET/CT) to see if it can predict whether your lung cancer has a specific gene change called EGFR mutation. If you have NSCLC and have already had an EGFR test, this study may help doctors find a less invasive way to check for that mutation in the future.
This study uses a computer-generated PET scan from your CT scan to help doctors diagnose and plan treatment for non-small cell lung cancer more precisely. It is observational, meaning no new treatments are given—just extra imaging analysis.
This study uses a special PET/CT scan to better tell if a lung nodule is non-small cell lung cancer. If you have a solid nodule in your lung that's at least 8 mm and might be cancer, this scan could help get a clearer diagnosis.
This trial is testing whether adding a PET/CT scan to routine follow-up care helps patients with stage III non-small cell lung cancer. It aims to see if this extra imaging can detect any return of cancer earlier, which may help with treatment decisions.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.